Delivery Order SPE2DB24D2105-SPE2DB25FANUR

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,151.23 firm fixed-price delivery order contract is for the supply of SPRYCEL 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,183.98 Firm Fixed Price Delivery Order contract is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,572.17 firm fixed-price delivery order covers the provision of SPRYCEL 70 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,322.18 fixed-price delivery order is for SPRYCEL 100 MG TABLET 30S, a specialty medication, with a completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,518.54 firm fixed-price delivery order is for the supply of SPRYCEL 20 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,703.94 firm fixed-price delivery order contract is for the supply of SPRYCEL 50 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $6,937.46 firm fixed-price delivery order covers the procurement of 4564930175 SPRYCEL 50 MG TABLET 60S, a specialty medication, for an ultimate completion date of June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,506.62, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract, valued at $22,765.85, is a Firm Fixed Price Delivery Order with a period of performance through January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $6,334.69 for the pharmaceutical product SPRYCEL 50 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 3, 2025. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB25FANUR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $46,211.20 Firm Fixed Price delivery order is for the supply of 4,566,144,081 SPRYCEL 100 MG Tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 1/17/25, 9:22 AM